<DOC>
	<DOCNO>NCT00532103</DOCNO>
	<brief_summary>This study develop new methodology evaluate treatment-emergent suicidal ideation might occur antidepressant treatment start and/or time dos increase patient major depressive disorder .</brief_summary>
	<brief_title>Assessing Treatment Emergent Suicidal Ideation Patients With Major Depression</brief_title>
	<detailed_description>This pilot study begin develop measurement procedure help guide clinical management suicide risk people begin type antidepressant medication call selective serotonin reuptake inhibitor ( SSRI ) . The goal study : 1 ) identify best method assessment measure evaluate severity suicidal ideation , 2 ) determine appropriate frequency duration assessment require adequately evaluate suicidal ideation , 3 ) evaluate presence symptom associate suicidal ideation ( anxiety , panic attack , difficulty sleep ) 4 ) identify critical time period suicidal ideation appear worsens ( long initiation treatment dosage increase ) . In , 300 adult participant major depressive disorder ( MDD ) , age 18 75 , may enrol primary psychiatric care sit across US . All patient treat SSRI eight week . The choice SSRI use treatment chosen study physician site . For study , physician choose follow six SSRIs : citalopram , escitalopram , sertraline , paroxetine , paroxetine-CR , fluoxetine . Patients begin SSRI MDD `` real world '' psychiatric primary care setting , clinic visit receive evaluation symptom depression , side effect , suicidal thinking symptom think associate suicidal risk , every week eight week . They evaluate phone symptom side effect week come clinic . They also receive phone call three time week first two week study , begin antidepressant , dose increase evaluate suicide risk .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Suicidal Ideation</mesh_term>
	<criteria>ONLY PATIENTS BEING TREATED AT THE PARTICIPATING CLINICS ARE ELIGIBLE FOR THIS STUDY Patients must enrol primary specialty care site , plan continue live area clinic throughout study Patients must 1875 year old Patients must meet clinical criterion MDD , base clinical interview DSM IV MDD checklist Screening HAMD17 score great equal 14 Patients must give write informed consent Patients without current suicidal ideation may include study Patients must take antidepressant medication least 2 week prior screen ( 4 week case fluoxetine ) . Current substance abuse dependence Two past SSRI treatment failure within current episode , last 2 year chronic . Patients current Axis I diagnosis Bipolar disorder Schizophrenia Patients current Primary Axis I diagnosis ObsessiveCompulsive disorder , Anorexia Nervosa Bulimia . Women sexually active use adequate contraception , pregnant , try become pregnant , breast feeding . Patients general medical condition contraindicate antidepressant medication Patients whose clinical status require inpatient treatment time baseline interview . Patients read understand English since research instrument yet translate validated Spanish language . Some report SSRIinduced akathisialike state find highly correlate either concurrent previous treatment neuroleptic , even patient history movement disorder therefore , patient take antipsychotic medication within 4 month screen visit exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Suicidal Ideation</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Suicide Risk</keyword>
	<keyword>Antidepressant Medication</keyword>
</DOC>